Bright future for Domilens as Chiron increases world intra-ocular lenses IOL stake
This article was originally published in Clinica
Executive Summary
Domilens' CEO Charles Roth-Meyer talked to Clinica's Jon Bryant about the company's takeover by Chiron and the future of intra-ocular lenses.